CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 238 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01047865
NCT01047865N/ACompleted
CompareCT.gov

Recurrence of T1D in Pancreas Transplantation

University of Miami·observational·Posted Jan 13, 2010·Updated May 29, 2026

In Brief

An observational study for Diabetes Mellitus, Type 1. Completed, enrolled 238 participants across 1 site.

Detailed Summary

The hypothesis is that humoral and cellular islet-specific responses are an early risk factor for recurrence of autoimmunity and hyperglycemia in simultaneous pancreas-kidney (SPK) recipients independent of alloimmunity. This study will test the hypothesis and will assess their individual and combined predictive value.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 13, 2010
Enrollment StartMay 1, 2005
Primary CompletionJan 5, 2026
TodayJul 2, 2026
Enrollment to primary: 20.7 yearsPosted 16.5 years ago